Literature DB >> 34083436

Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine.

Glenn Dallérac1,2, Xia Li2, Pierre Lecouflet3, Nadège Morisot4, Silvia Sacchi5, Rachel Asselot6, Thu Ha Pham7, Brigitte Potier3, David J G Watson8, Staffan Schmidt9, Grégoire Levasseur10, Pascal Fossat11, Andrey Besedin6, Jean-Michel Rivet12, Joseph T Coyle13,14, Ginetta Collo15, Loredano Pollegioni5, Jan Kehr9, Micaela Galante2, Kevin C Fone8, Alain M Gardier7, Thomas Freret6, Angelo Contarino4, Mark J Millan12, Jean-Pierre Mothet1,3.   

Abstract

Prefrontal control of cognitive functions critically depends upon glutamatergic transmission and N-methyl D-aspartate (NMDA) receptors, the activity of which is regulated by dopamine. Yet whether the NMDA receptor coagonist d-serine is implicated in the dopamine-glutamate dialogue in the prefrontal cortex (PFC) and other brain areas remains unexplored. Here, using electrophysiological recordings, we show that d-serine is required for the fine-tuning of glutamatergic neurotransmission, neuronal excitability, and synaptic plasticity in the PFC through the actions of dopamine at D1 and D3 receptors. Using in vivo microdialysis, we show that D1 and D3 receptors exert a respective facilitatory and inhibitory influence on extracellular levels and activity of d-serine in the PFC, with actions expressed primarily via the cAMP/protein kinase A (PKA) signaling cascade. Further, using functional magnetic resonance imaging (fMRI) and behavioral assessment, we show that d-serine is required for the potentiation of cognition by D3R blockade as revealed in a test of novel object recognition memory. Collectively, these results unveil a key role for d-serine in the dopaminergic neuromodulation of glutamatergic transmission and PFC activity, findings with clear relevance to the pathogenesis and treatment of diverse brain disorders involving alterations in dopamine-glutamate cross-talk.

Entities:  

Keywords:  D1- and D2-type receptors; NMDA receptors; d-serine; schizophrenia; serine racemase knockout mice

Mesh:

Substances:

Year:  2021        PMID: 34083436      PMCID: PMC8201892          DOI: 10.1073/pnas.2023750118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes.

Authors:  Shunske Tanahashi; Satoshi Yamamura; Masanori Nakagawa; Eishi Motomura; Motohiro Okada
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  A genetic variant of the serine racemase gene is associated with schizophrenia.

Authors:  Yukitaka Morita; Hiroshi Ujike; Yuji Tanaka; Kyohei Otani; Makiko Kishimoto; Akiko Morio; Tatsuya Kotaka; Yuko Okahisa; Masayuki Matsushita; Akiko Morikawa; Kenji Hamase; Kiyoshi Zaitsu; Shigetoshi Kuroda
Journal:  Biol Psychiatry       Date:  2006-10-25       Impact factor: 13.382

3.  D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons.

Authors:  J Wang; P O'Donnell
Journal:  Cereb Cortex       Date:  2001-05       Impact factor: 5.357

4.  Blonanserin ameliorates social deficit through dopamine-D3 receptor antagonism in mice administered phencyclidine as an animal model of schizophrenia.

Authors:  Saori Takeuchi; Hirotake Hida; Mizuki Uchida; Ryo Naruse; Akira Yoshimi; Shinji Kitagaki; Norio Ozaki; Yukihiro Noda
Journal:  Neurochem Int       Date:  2019-04-16       Impact factor: 3.921

5.  D1 and D2 dopamine receptors in separate circuits cooperate to drive associative long-term potentiation in the prefrontal cortex.

Authors:  Tai-Xiang Xu; Wei-Dong Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

Review 6.  The principal features and mechanisms of dopamine modulation in the prefrontal cortex.

Authors:  Jeremy K Seamans; Charles R Yang
Journal:  Prog Neurobiol       Date:  2004-09       Impact factor: 11.685

7.  The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle.

Authors:  Samah Neame; Hazem Safory; Inna Radzishevsky; Ayelet Touitou; Francesco Marchesani; Marialaura Marchetti; Shai Kellner; Shai Berlin; Veronika N Foltyn; Simone Engelender; Jean-Marie Billard; Herman Wolosker
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

Review 8.  Dopaminergic modulation of synaptic transmission in cortex and striatum.

Authors:  Nicolas X Tritsch; Bernardo L Sabatini
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

9.  Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.

Authors:  Darrick T Balu; Yan Li; Matthew D Puhl; Michael A Benneyworth; Alo C Basu; Shunsuke Takagi; Vadim Y Bolshakov; Joseph T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-31       Impact factor: 11.205

Review 10.  Cell-type specific mechanisms of D-serine uptake and release in the brain.

Authors:  Magalie Martineau; Vladimir Parpura; Jean-Pierre Mothet
Journal:  Front Synaptic Neurosci       Date:  2014-05-30
View more
  5 in total

Review 1.  Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia.

Authors:  Silas A Buck; M Quincy Erickson-Oberg; Ryan W Logan; Zachary Freyberg
Journal:  Mol Psychiatry       Date:  2022-06-10       Impact factor: 13.437

2.  Neurobiology of Psychosis and Schizophrenia 2021: Nottingham Meeting.

Authors:  Musa Basseer Sami; Peter Liddle
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 9.306

Review 3.  N-Acetyl-Aspartyl-Glutamate in Brain Health and Disease.

Authors:  Cecilie Morland; Kaja Nordengen
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

Review 4.  Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics.

Authors:  Andrea de Bartolomeis; Licia Vellucci; Mark C Austin; Giuseppe De Simone; Annarita Barone
Journal:  Biomolecules       Date:  2022-06-29

Review 5.  Insights into the Promising Prospect of G Protein and GPCR-Mediated Signaling in Neuropathophysiology and Its Therapeutic Regulation.

Authors:  Md Mominur Rahman; Md Rezaul Islam; Sadia Afsana Mim; Nasrin Sultana; Dinesh Kumar Chellappan; Kamal Dua; Mohammad Amjad Kamal; Rohit Sharma; Talha Bin Emran
Journal:  Oxid Med Cell Longev       Date:  2022-09-21       Impact factor: 7.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.